Since we observed that mefunidone could improve mitochondrial damage and that the mitochondrial pathway is the most important apoptotic mechanism in AKI, we examined whether mefunidone treatment abated IRI-mediated renal apoptosis by inhibiting the expression of mitochondrial-related pro-apoptotic proteins. This evidence concerns the gene PROS1 and acute kidney injury.